Literature DB >> 32168258

Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial: Erratum.

.   

Abstract

Entities:  

Year:  2020        PMID： 32168258      PMCID： PMC7526567          DOI： 10.1097/MPA.0000000000001517

Source DB:  PubMed          Journal:  Pancreas        ISSN： 0885-3177            Impact factor:   3.243


× No keyword cloud information.
  1 in total

1.  Liposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treatment Characteristics in the Pivotal NAPOLI-1 Trial.

Authors:  Teresa Macarulla Mercadé; Li-Tzong Chen; Chung-Pin Li; Jens T Siveke; David Cunningham; György Bodoky; Jean-Frédéric Blanc; Kyung-Hun Lee; Andrew Dean; Bruce Belanger; Andrea Wang-Gillam
Journal:  Pancreas       Date:  2020-01       Impact factor: 3.327
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.